Glaucoma Therapeutics Market Report

China Glaucoma Therapeutics Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Aug 23, 2022
  • PAGES：159
  • REPORT CODE：GMM1114661
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Glaucoma is a disease of eye which is caused by excessive increase of fluid pressure within the eye. Glaucoma is caused due to mechanical compression or decreased blood flow in the optic nerve of the patient’s eye. If not treated properly, it may lead to mild loss of vision and even blindness. Treatment of glaucoma includes laser therapies, pharmaceutical drugs and surgical procedures.

    This report offers an overview of the market trends, drivers, and barriers with respect to the China Glaucoma Therapeutics market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Glaucoma Therapeutics market. Detailed analysis of key players, along with key growth strategies adopted by Glaucoma Therapeutics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Allergan

    • Pfizer

    • Merck

    • Santen Pharmaceuticals

    • Aerie Pharmaceuticals

    • Novartis

    • Valeant Pharmaceuticals

    By Type:

    • Beta Blockers

    • Prostaglandin

    • Latanoprost

    • Bimatoprost

    • Travoprost

    • Alpha adrenergic Agonist

    • Carbonic Anhydrase Inhibitor

    • Combinations Drugs

    • Others

    By End-User:

    • Hospitals

    • Ophthalmic Clinics

    • Ambulatory Surgical Centers

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Glaucoma Therapeutics Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Glaucoma Therapeutics Market Size and Growth Rate of Beta Blockers from 2016 to 2027

    • 1.3.2 China Glaucoma Therapeutics Market Size and Growth Rate of Prostaglandin from 2016 to 2027

    • 1.3.3 China Glaucoma Therapeutics Market Size and Growth Rate of Latanoprost from 2016 to 2027

    • 1.3.4 China Glaucoma Therapeutics Market Size and Growth Rate of Bimatoprost from 2016 to 2027

    • 1.3.5 China Glaucoma Therapeutics Market Size and Growth Rate of Travoprost from 2016 to 2027

    • 1.3.6 China Glaucoma Therapeutics Market Size and Growth Rate of Alpha adrenergic Agonist from 2016 to 2027

    • 1.3.7 China Glaucoma Therapeutics Market Size and Growth Rate of Carbonic Anhydrase Inhibitor from 2016 to 2027

    • 1.3.8 China Glaucoma Therapeutics Market Size and Growth Rate of Combinations Drugs from 2016 to 2027

    • 1.3.9 China Glaucoma Therapeutics Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Glaucoma Therapeutics Market Size and Growth Rate of Hospitals from 2016 to 2027

    • 1.4.2 China Glaucoma Therapeutics Market Size and Growth Rate of Ophthalmic Clinics from 2016 to 2027

    • 1.4.3 China Glaucoma Therapeutics Market Size and Growth Rate of Ambulatory Surgical Centers from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Glaucoma Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Glaucoma Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Glaucoma Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Glaucoma Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Glaucoma Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Glaucoma Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Glaucoma Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Glaucoma Therapeutics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Glaucoma Therapeutics by Major Types

    • 3.4.1 Market Size and Growth Rate of Beta Blockers

    • 3.4.2 Market Size and Growth Rate of Prostaglandin

    • 3.4.3 Market Size and Growth Rate of Latanoprost

    • 3.4.4 Market Size and Growth Rate of Bimatoprost

    • 3.4.5 Market Size and Growth Rate of Travoprost

    • 3.4.6 Market Size and Growth Rate of Alpha adrenergic Agonist

    • 3.4.7 Market Size and Growth Rate of Carbonic Anhydrase Inhibitor

    • 3.4.8 Market Size and Growth Rate of Combinations Drugs

    • 3.4.9 Market Size and Growth Rate of Others

    4 Segmentation of Glaucoma Therapeutics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Glaucoma Therapeutics by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Glaucoma Therapeutics in Hospitals

    • 4.4.2 Market Size and Growth Rate of Glaucoma Therapeutics in Ophthalmic Clinics

    • 4.4.3 Market Size and Growth Rate of Glaucoma Therapeutics in Ambulatory Surgical Centers

    5 Market Analysis by Regions

    • 5.1 China Glaucoma Therapeutics Production Analysis by Regions

    • 5.2 China Glaucoma Therapeutics Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Glaucoma Therapeutics Landscape Analysis

    • 6.1 North China Glaucoma Therapeutics Landscape Analysis by Major Types

    • 6.2 North China Glaucoma Therapeutics Landscape Analysis by Major End-Users

    7 Central China Glaucoma Therapeutics Landscape Analysis

    • 7.1 Central China Glaucoma Therapeutics Landscape Analysis by Major Types

    • 7.2 Central China Glaucoma Therapeutics Landscape Analysis by Major End-Users

    8 South China Glaucoma Therapeutics Landscape Analysis

    • 8.1 South China Glaucoma Therapeutics Landscape Analysis by Major Types

    • 8.2 South China Glaucoma Therapeutics Landscape Analysis by Major End-Users

    9 East China Glaucoma Therapeutics Landscape Analysis

    • 9.1 East China Glaucoma Therapeutics Landscape Analysis by Major Types

    • 9.2 East China Glaucoma Therapeutics Landscape Analysis by Major End-Users

    10 Northeast China Glaucoma Therapeutics Landscape Analysis

    • 10.1 Northeast China Glaucoma Therapeutics Landscape Analysis by Major Types

    • 10.2 Northeast China Glaucoma Therapeutics Landscape Analysis by Major End-Users

    11 Southwest China Glaucoma Therapeutics Landscape Analysis

    • 11.1 Southwest China Glaucoma Therapeutics Landscape Analysis by Major Types

    • 11.2 Southwest China Glaucoma Therapeutics Landscape Analysis by Major End-Users

    12 Northwest China Glaucoma Therapeutics Landscape Analysis

    • 12.1 Northwest China Glaucoma Therapeutics Landscape Analysis by Major Types

    • 12.2 Northwest China Glaucoma Therapeutics Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Allergan

      • 13.1.1 Allergan Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Pfizer

      • 13.2.1 Pfizer Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Merck

      • 13.3.1 Merck Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Santen Pharmaceuticals

      • 13.4.1 Santen Pharmaceuticals Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Aerie Pharmaceuticals

      • 13.5.1 Aerie Pharmaceuticals Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Novartis

      • 13.6.1 Novartis Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Valeant Pharmaceuticals

      • 13.7.1 Valeant Pharmaceuticals Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Glaucoma Therapeutics Market Size and Growth Rate of Beta Blockers from 2016 to 2027

    • Figure China Glaucoma Therapeutics Market Size and Growth Rate of Prostaglandin from 2016 to 2027

    • Figure China Glaucoma Therapeutics Market Size and Growth Rate of Latanoprost from 2016 to 2027

    • Figure China Glaucoma Therapeutics Market Size and Growth Rate of Bimatoprost from 2016 to 2027

    • Figure China Glaucoma Therapeutics Market Size and Growth Rate of Travoprost from 2016 to 2027

    • Figure China Glaucoma Therapeutics Market Size and Growth Rate of Alpha adrenergic Agonist from 2016 to 2027

    • Figure China Glaucoma Therapeutics Market Size and Growth Rate of Carbonic Anhydrase Inhibitor from 2016 to 2027

    • Figure China Glaucoma Therapeutics Market Size and Growth Rate of Combinations Drugs from 2016 to 2027

    • Figure China Glaucoma Therapeutics Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Glaucoma Therapeutics Market Size and Growth Rate of Hospitals from 2016 to 2027

    • Figure China Glaucoma Therapeutics Market Size and Growth Rate of Ophthalmic Clinics from 2016 to 2027

    • Figure China Glaucoma Therapeutics Market Size and Growth Rate of Ambulatory Surgical Centers from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Glaucoma Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Glaucoma Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Glaucoma Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Glaucoma Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Glaucoma Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Glaucoma Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Glaucoma Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Glaucoma Therapeutics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Glaucoma Therapeutics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Glaucoma Therapeutics by Different Types from 2016 to 2027

    • Table Consumption Share of Glaucoma Therapeutics by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Beta Blockers

    • Figure Market Size and Growth Rate of Prostaglandin

    • Figure Market Size and Growth Rate of Latanoprost

    • Figure Market Size and Growth Rate of Bimatoprost

    • Figure Market Size and Growth Rate of Travoprost

    • Figure Market Size and Growth Rate of Alpha adrenergic Agonist

    • Figure Market Size and Growth Rate of Carbonic Anhydrase Inhibitor

    • Figure Market Size and Growth Rate of Combinations Drugs

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Glaucoma Therapeutics by Different End-Users from 2016 to 2027

    • Table Consumption Share of Glaucoma Therapeutics by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Ophthalmic Clinics

    • Figure Market Size and Growth Rate of Ambulatory Surgical Centers

    • Table China Glaucoma Therapeutics Production by Regions

    • Table China Glaucoma Therapeutics Production Share by Regions

    • Figure China Glaucoma Therapeutics Production Share by Regions in 2016

    • Figure China Glaucoma Therapeutics Production Share by Regions in 2021

    • Figure China Glaucoma Therapeutics Production Share by Regions in 2027

    • Table China Glaucoma Therapeutics Consumption by Regions

    • Table China Glaucoma Therapeutics Consumption Share by Regions

    • Figure China Glaucoma Therapeutics Consumption Share by Regions in 2016

    • Figure China Glaucoma Therapeutics Consumption Share by Regions in 2021

    • Figure China Glaucoma Therapeutics Consumption Share by Regions in 2027

    • Table North China Glaucoma Therapeutics Consumption by Types from 2016 to 2027

    • Table North China Glaucoma Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure North China Glaucoma Therapeutics Consumption Share by Types in 2016

    • Figure North China Glaucoma Therapeutics Consumption Share by Types in 2021

    • Figure North China Glaucoma Therapeutics Consumption Share by Types in 2027

    • Table North China Glaucoma Therapeutics Consumption by End-Users from 2016 to 2027

    • Table North China Glaucoma Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure North China Glaucoma Therapeutics Consumption Share by End-Users in 2016

    • Figure North China Glaucoma Therapeutics Consumption Share by End-Users in 2021

    • Figure North China Glaucoma Therapeutics Consumption Share by End-Users in 2027

    • Table Central China Glaucoma Therapeutics Consumption by Types from 2016 to 2027

    • Table Central China Glaucoma Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure Central China Glaucoma Therapeutics Consumption Share by Types in 2016

    • Figure Central China Glaucoma Therapeutics Consumption Share by Types in 2021

    • Figure Central China Glaucoma Therapeutics Consumption Share by Types in 2027

    • Table Central China Glaucoma Therapeutics Consumption by End-Users from 2016 to 2027

    • Table Central China Glaucoma Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Glaucoma Therapeutics Consumption Share by End-Users in 2016

    • Figure Central China Glaucoma Therapeutics Consumption Share by End-Users in 2021

    • Figure Central China Glaucoma Therapeutics Consumption Share by End-Users in 2027

    • Table South China Glaucoma Therapeutics Consumption by Types from 2016 to 2027

    • Table South China Glaucoma Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure South China Glaucoma Therapeutics Consumption Share by Types in 2016

    • Figure South China Glaucoma Therapeutics Consumption Share by Types in 2021

    • Figure South China Glaucoma Therapeutics Consumption Share by Types in 2027

    • Table South China Glaucoma Therapeutics Consumption by End-Users from 2016 to 2027

    • Table South China Glaucoma Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure South China Glaucoma Therapeutics Consumption Share by End-Users in 2016

    • Figure South China Glaucoma Therapeutics Consumption Share by End-Users in 2021

    • Figure South China Glaucoma Therapeutics Consumption Share by End-Users in 2027

    • Table East China Glaucoma Therapeutics Consumption by Types from 2016 to 2027

    • Table East China Glaucoma Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure East China Glaucoma Therapeutics Consumption Share by Types in 2016

    • Figure East China Glaucoma Therapeutics Consumption Share by Types in 2021

    • Figure East China Glaucoma Therapeutics Consumption Share by Types in 2027

    • Table East China Glaucoma Therapeutics Consumption by End-Users from 2016 to 2027

    • Table East China Glaucoma Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure East China Glaucoma Therapeutics Consumption Share by End-Users in 2016

    • Figure East China Glaucoma Therapeutics Consumption Share by End-Users in 2021

    • Figure East China Glaucoma Therapeutics Consumption Share by End-Users in 2027

    • Table Northeast China Glaucoma Therapeutics Consumption by Types from 2016 to 2027

    • Table Northeast China Glaucoma Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Glaucoma Therapeutics Consumption Share by Types in 2016

    • Figure Northeast China Glaucoma Therapeutics Consumption Share by Types in 2021

    • Figure Northeast China Glaucoma Therapeutics Consumption Share by Types in 2027

    • Table Northeast China Glaucoma Therapeutics Consumption by End-Users from 2016 to 2027

    • Table Northeast China Glaucoma Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Glaucoma Therapeutics Consumption Share by End-Users in 2016

    • Figure Northeast China Glaucoma Therapeutics Consumption Share by End-Users in 2021

    • Figure Northeast China Glaucoma Therapeutics Consumption Share by End-Users in 2027

    • Table Southwest China Glaucoma Therapeutics Consumption by Types from 2016 to 2027

    • Table Southwest China Glaucoma Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Glaucoma Therapeutics Consumption Share by Types in 2016

    • Figure Southwest China Glaucoma Therapeutics Consumption Share by Types in 2021

    • Figure Southwest China Glaucoma Therapeutics Consumption Share by Types in 2027

    • Table Southwest China Glaucoma Therapeutics Consumption by End-Users from 2016 to 2027

    • Table Southwest China Glaucoma Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Glaucoma Therapeutics Consumption Share by End-Users in 2016

    • Figure Southwest China Glaucoma Therapeutics Consumption Share by End-Users in 2021

    • Figure Southwest China Glaucoma Therapeutics Consumption Share by End-Users in 2027

    • Table Northwest China Glaucoma Therapeutics Consumption by Types from 2016 to 2027

    • Table Northwest China Glaucoma Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Glaucoma Therapeutics Consumption Share by Types in 2016

    • Figure Northwest China Glaucoma Therapeutics Consumption Share by Types in 2021

    • Figure Northwest China Glaucoma Therapeutics Consumption Share by Types in 2027

    • Table Northwest China Glaucoma Therapeutics Consumption by End-Users from 2016 to 2027

    • Table Northwest China Glaucoma Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Glaucoma Therapeutics Consumption Share by End-Users in 2016

    • Figure Northwest China Glaucoma Therapeutics Consumption Share by End-Users in 2021

    • Figure Northwest China Glaucoma Therapeutics Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Allergan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan

    • Figure Sales and Growth Rate Analysis of Allergan

    • Figure Revenue and Market Share Analysis of Allergan

    • Table Product and Service Introduction of Allergan

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Santen Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Santen Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Santen Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Santen Pharmaceuticals

    • Table Product and Service Introduction of Santen Pharmaceuticals

    • Table Company Profile and Development Status of Aerie Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aerie Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Aerie Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Aerie Pharmaceuticals

    • Table Product and Service Introduction of Aerie Pharmaceuticals

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Valeant Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeant Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Valeant Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Valeant Pharmaceuticals

    • Table Product and Service Introduction of Valeant Pharmaceuticals


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US